Aug. 19 at 9:04 AM
$IBB $OXLC $GILD $HUT IBB provides diversified biotechnology exposure, Oxford Lane benefits from credit-market conditions, Gilead benefits from its pharmaceutical portfolio, and Hut 8 benefits from Bitcoin and data-center infrastructure demand. I'm watching biotech catalysts, credit spreads, drug sales, Bitcoin prices, and power capacity.